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To identify the genetic basis of the differences between chimpanzees and humans, it is indispensable to analyze a whole gene set constituting a
particular regulatory system as well as to compare the whole genome or chromosomes randomly. We compared genes encoding hormones of the
endocrine system, one of the most fundamental regulatory systems in organisms. The present study covered a total of 111 genes generating 115
precursors and 172 peptides. Decisive differences were observed in GNRH2 and UCN2 and their corresponding receptor genes. It is often
postulated that mechanisms underlying the basic functions of life are common and would not be readily altered. The present study demonstrated
that, on the contrary, substantial differences have been generated in genes composing the endocrine system, even between humans and our closest
living relative.
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Since large-scale sequence data of the genome of the
chimpanzee (Pan troglodytes) are being accumulated and
deposited in public databases, it is becoming increasingly
possible to compare the entire chimpanzee genome with the
human genome. A number of studies comparing the two
genomes have been conducted to identify the genetic basis of
the present-day physical, physiological, and behavioral differ-
ences between chimpanzees and humans [1–5]. However, much
less attention has been directed toward analyzing a whole gene
set constituting a particular regulatory system composed of
diverse members and examining the similarities and differences
between the two species. In the present study, we focused on
genes encoding hormones of the endocrine system, which
regulate a vast variety of biological processes, including
reproduction, growth and development, metabolism, and
homeostasis.⁎ Corresponding author. Fax: +81 3 5841 4439.
E-mail address: tikemoto@infoseek.jp (T. Ikemoto).
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It was found that the average nucleotide substitution level in
the entire open reading frame of precursor sequences was
approximately 0.83% (Table 1). Therefore, the overall identity
between humans and chimpanzees in the coding sequences for
the endocrine hormones (99.17%) is higher than that in the
genome sequences (98.77%) [3] and that in a single particular
chromosome (98.56%) [5]. However, the average number of
non-synonymous substitutions (0.46%) was higher than that of
synonymous substitutions (0.37%). For the regions of mature
peptides, the average nucleotide sequence identity was slightly
higher (99.28%) than that of the precursors. In the coding
sequences for mature peptides, the average number of non-
synonymous substitutions (0.35%) was almost the same as that
of synonymous substitutions (0.37%). Fifty-one percent of
mature peptides were completely conserved at the nucleotide
level, though 91% of precursors had nucleotide divergences.
It is notable that the average identity at the amino acid level
(precursors, 98.74%; mature peptides, 99.09%) was lower than
that at the nucleotide level. It was found that 45 mature peptides
(26%) would differ at the amino acid level. This rate is much
lower than the calculation based on a particular chromosome
Table 1
Comparison of precursors and mature peptides of endocrine systems in humans
and chimpanzees
Precursors Mature peptides
Total No. 115 172
With nt divergence 105 84
With aa divergence 89 45
Average % nt divergence 0.83 0.72
Non-synonymous 0.46 0.35
Synonymous 0.37 0.37
Average % aa divergence 1.26 0.91
Non-conservative 1.06 0.81
Conservative 0.20 0.10
Average % KA 0.61 0.46
Average % KS 1.50 1.47
KA N KS 27 24
Note. nt, nucleotide; aa, amino acid.
460 T. Ikemoto, M.K. Park / Genomics 87 (2006) 459–462(83%) [3] and the average protein difference (80%) [6], as
expected, suggesting the functional and physiological impor-
tance of and the evolutionary constraints on the endocrine
system. However, most amino acid differences might cause
significant structural changes of mature peptides. The average
number of non-conservative amino acid substitutions, which
would be more likely to have a direct functional effect, was
much higher (1.06%; 0.81%) than that of conservative
substitutions (0.20%; 0.10%).
Thirty-five mature peptides (20%) showed non-conservative
amino acid changes. Their corresponding receptor genes (12
such genes are known thus far) were also searched for
comparison between humans and chimpanzees (Supplementary
Table 1). Ten of them (83%) had non-conservative amino acid
changes (Table 2), supporting a theory of ligand–receptor co-
evolution. As in the case of ligands, the average number of non-
conservative amino acid substitutions in their receptors was
higher (0.47%) than that of conservative substitutions (0.19%)
(Supplementary Table 1). Whether this divergence affects
ligand–receptor binding, subcellular signaling pathways, and
physiological functions themselves needs to be further
examined in future studies.
The number of synonymous substitutions per synonymous
site (KS) and the number of non-synonymous substitutions per
non-synonymous site (KA) were calculated using DnaSP
software [7] (Supplementary Table 2). These values can be
used to assess the neutrality of sequence differences found
between orthologous gene pairs of two species. The average KA
and KS were 0.46 and 1.47% for mature peptides, respectively,Table 2
Corresponding receptors for mature peptides having non-conservative amino
acid changes in humans and chimpanzees
Receptors
Total No. 12
With aa divergence 10
Average % aa divergence 0.66
Non-conservative 0.47
Conservative 0.19
Note. aa, amino acid.and both were smaller than those for precursors (0.61%; 1.50%)
(Table 1).
The KA/KS ratio, which provides a measure of evolutionary
selection, was calculated for each gene. A KA/KS ratio (nearly)
equal to 1 indicates neutrality. A KA/KS ratio of greater than 1
indicates positive selection, whereas a KA/KS ratio of substan-
tially less than 1 indicates negative or purifying selection. There
were 27 precursors (23%) and 24 mature peptides (14%) having
a KA/KS ratio of greater than 1, i.e., KA larger than KS. It is of
great interest that these values are much higher than the
calculation based on an entire chromosome (10%) [5].
Corresponding receptor genes of each mature peptide having
KA larger thanKS (nine such genes are known thus far) were also
compared between the two species (Supplementary Table 3). As
in the case of their ligands, the rate of receptors having KA larger
than KS (22%) was greater than that for an entire chromosome.
Regarding the endocrine systems of humans and chim-
panzees, decisive differences were observed in two genes,
GNRH2 and UCN2. In chimpanzees, both appeared to be
pseudogenes as they contained a premature stop codon. In
contrast, humans express both genes [8,9]. GNRH2 is the
gene encoding an evolutionarily highly conserved neuropep-
tide. GNRH2 peptide has been found to be universally present
and uniquely conserved among jawed vertebrates, including
humans, without any sequence substitutions [10]. The
physiological function of GNRH2 in humans is completely
unknown despite the fact that GnRH analogues, both agonists
and antagonists, are widely applied in the clinical field against
several cancers based on their antiproliferative effects [11,12].
UCN2 is the gene encoding a selective agonist for the type 2
corticotropin-releasing hormone receptor (CRHR2). It has
been suggested that UCN2 is involved in the control of
myometrial contractility during pregnancy in humans [13].
The precursor sequence of human UCN2 lacks a carboxy-
terminal amidation/proteolytic processing signal conserved in
all the CRH family including chimpanzee UCN2. Since non-
amidated UCN2 showed a 98% reduction in its activity [9], it
is of interest whether the endogenous human UCN2 is
functional in vivo or non-functional like the chimpanzee
orthologue.
The corresponding receptor genes for GNRH2 and UCN2
(GNRHR2 and CRHR2, respectively) also showed marked
differences between the two species. GNRHR2 is the gene
encoding the G-protein-coupled receptor specific for GNRH2
in primates [10]. Human GNRHR2 contains a frameshift and a
premature stop codon and therefore presumably would notFig. 1. Schematic diagrams of the human GNRHR2 gene. Boxes and horizontal
lines indicate exons and introns, respectively. Putative open reading frame
regions are shaded. (A) The canonical heptahelical protein model. Human
GNRHR2 contains a frameshift and a premature stop codon. (B) A splice variant.
Fig. 2. The human and chimpanzee CRHR2 isoforms. Nucleotides in capitals indicate open reading frame regions. (A) The CRHR2 beta sequence. The initiation
codon is mutated in chimpanzees. (B) The CRHR2 gamma sequence. The chimpanzee CRHR2 gamma contains a single base deletion.
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chimpanzee GNRHR2 also contains a frameshift and a
premature stop codon in the same positions as in the human
gene. The KA/KS ratio based on the region for the putative
heptahelical protein was calculated as 1.05, indicating rather
positive selection. On the other hand, the KA/KS ratio based
on a shorter splice variant sequence, which is expressed in a
prostatic adenocarcinoma cell line and placenta in humans
(Accession Nos. BI850619 and DQ266410; Fig. 1B), was
only 0.36. The functional significance of the human
GNRHR2 and its splice variant has been focused on in
several studies [14,15]. Humans express three isotypes of
CRHR2 (types alpha, beta, and gamma) by alternative exon–
intron usage. Each KA/KS ratio was relatively low (0.24,
0.36, and 0.19, respectively), but two of them would not
generate complete proteins in chimpanzees (Fig. 2). The
initiation codon of CRHR2 beta was mutated in chimpan-
zees, resulting in at least an amino-terminal deletion of 36
amino acid residues (Fig. 2A). The chimpanzee CRHR2
gamma contained a single base deletion, which might cause
a deletion of 150 residues or an insertion of 11 residues at
the amino-terminus (Fig. 2B). The similarity between the
GNRH and the UCN systems is that both consist of multiple
ligands and receptors. Although the intensity of ligand–
receptor interaction would differ, a ligand might interact with
a receptor for its paralogue. In fact, GNRH1, the paralogue
of GNRH2, can activate GNRHR2 [16], and UCN, UCN3,
and CRH, paralogues of UCN2, can activate CRHR2 [9].
Gene multiplication is one of the main driving forces of
evolution and enables functional diversity. The existence of
pseudogenes may indicate that the function of a gene is
replaced by that of a paralogous gene or other bioactive
substances or that its role is redundant and unnecessary.
From these perspectives, it is important to investigate the
biological effects of the differences in the GNRH and UCN
systems between humans and chimpanzees.
It is often postulated that the mechanisms underlying the
basic functions of life are common to many species and
cannot be altered readily. The present results demonstratedthat, on the contrary, substantial differences have been
generated in genes composing the endocrine system, even
between humans and our closest living relative. Several
studies showed that many differences between the two
species may be due to quantitative differences in gene
expression in the brain [17,18]. The divergence and higher
rates of evolution observed in endocrine and neuroendocrine
systems, especially the formation of some pseudogenes in
chimpanzees, may affect the expression patterns and, as a
result, cause physical, physiological, and behavioral differ-
ences between the two species. A further challenge will be to
clarify how many of the differences have functional
consequences and to identify differences that account for
present-day differences between the two species. The
biological consequences of the genomic differences observed
should be carefully examined.
Materials and methods
Using the NCBI Trace Archive, we have compared 111 genes
generating 115 precursors and 172 peptides including both common
“classic” endocrine hormones and recently identified neuropeptides (Sup-
plementary Table 2). These also cover all the peptides listed in the AmiGO
database (http://www.godatabase.org/cgi-bin/amigo/go.cgi) as having hor-
mone activity and/or neuropeptide hormone activity in humans. The quality
and accuracy of the sequence data were validated by checking each trace
file. The KS and KA values were calculated using the DnaSP software [7]
(Supplementary Table 2).Acknowledgments
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Appendix A. Supplementary data
Supplementary data associated with this article can be found
in the online version at doi:10.1016/j.ygeno.2005.11.005.
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